Table 2.
Maternal and neonatal outcomes.
| Outcomes | Intervention Group (n = 19) | Non-Intervention Group (n = 47) | p-Value |
|---|---|---|---|
| Maternal outcomes | |||
| Total EBL | 1000 (400–6500) | 1000 (400–5000) | 0.637 |
| Massive hemorrhage (≥1500 mL) | 6 (32%) | 15 (32%) | 0.979 |
| Transfusion of packed red blood cells | 5 (26%) | 11 (23%) | 0.517 |
| Units of packed red blood cells transfused | 0 (0–16) | 0 (0–5) | 0.699 |
| Transfusion of platelet, fresh frozen plasma, or cryoprecipitate | 4 (21%) | 5 (10.6%) | 0.267 |
| Uterine artery embolization after an operation | 1 (0.05%) | 0 | - |
| Hysterectomy | 7 (37%) | 2 (4%) | 0.002 |
| Relaparotomy | 1 (5.26%) | 1 (2.13%) | - |
| Intensive care unit admission (≥2 days) | 3 (16%) | 3 (6%) | 0.344 |
| Postoperative hospital stay | 6 (2–13) | 6 (3–15) | 0.657 |
| Neonatal outcomes | |||
| APGAR score at 1 min | 8 (5–9) | 8 (5–10) | 0.507 |
| APGAR score at 5 min | 9 (6–10) | 9 (7–10) | 0.882 |
Data are shown as median (min–max) or number (%). (-)—not calculated due to lack of data.